Rebirth 90: I opened a hospital in Shencheng

Chapter 427 The advantage of a hundred times price difference in targeted drugs!

A calm and pleasant mood is good for the stability of the condition.

Nie Chen hopes that Zhao Po can live a happy life instead of being obsessed with his disciple's incompetence.

Zhao Po nodded and said, "I know that I don't have much time left, and I also know that Dr. Nie persuaded me for my own good, how about this, I will let Zhao Chunrong come back for dinner in two days, and we will walk more between father and son in the future move!"

After experiencing life and death, Zhao Po also saw it, his children and grandchildren have his own children and grandchildren, Qicheng, he has arranged enough for Zhao Chunrong, let him walk the rest of his life path!
Nie Chen had a meal at Zhao Po's house.

When leaving, Zhao Po's wife sent him outside the door and said, "Thank you this time, Dr. Nie, you don't even know how stubborn the two of them are. I want them to reconcile, no matter how many times I tell the old man, he doesn't listen to persuasion, and the two of you can't see each other several times a year!"

"Maybe it's Mr. Zhao who has experienced a life-and-death experience. Maybe it's because I'm just an outsider and he doesn't feel embarrassed to refute me!"

"I don't think I've done anything special either!"

Nie Chen said.

He left Zhao Po's house calmly.

The neighbors looked at Nie Chen curiously.

Zhao Po's status is special, so it can be said that there is nothing wrong with him, but even those well-known lawyers, courts, and procuratorates came to visit Zhao Po and his wife and they never sent their guests out.

But I don't know who Nie Chen is?

Why did Zhao Po's wife personally send him out and even greet him with a smile?
Sure enough, there was some tension between Zhao Po and Zhao Chunrong and his son.

A few days later, Zhao Po called and asked his son to go home for dinner.

Zhao Chunrong was flattered.

At the dinner table, Zhao Po apologized to Zhao Chunrong, saying that he had been too strict with him all these years, and that from now on, he would choose all the paths he would take.

Zhao Chunrong shed tears happily.

Three months after its release, Ibrutinib has won recognition from patients and medical staff for its excellent curative effect.

The Ministry of Health announced that it will be included in the medical insurance reimbursement list like other conventional drugs.

The sales volume of ibrutinib increased significantly.

From now on, late stage cancer is no longer synonymous with death.

Even if the patient is found to be in the late stage or even the terminal stage of cancer, he may live for several months or even years.

Some patients with good treatment results can even live for more than five years by taking drugs and surgery.

Just when ibrutinib was launched in China and sold like a raging fire, many scientific research and medical institutions paid attention to this drug.

The Journal of the American Cancer Society publicly expressed its expectation for this drug. The magazine said that medicine knows no borders, and hoped that this new drug could enter the United States as soon as possible, bringing new hope to the majority of cancer patients.

The medical branch of "Nature Magazine" also highly praised this drug, saying that the drug is the gospel of the majority of cancer patients, and fully affirmed Nie Chen's contribution to human beings in medicine and pharmacology, saying that this is not inferior to his previous invention. The pioneering work of Ren Zhaopo's medicine.

The China Food and Drug Administration (FDA) also expressed concern about ibrutinib produced by Xinda Pharmaceuticals and sent an invitation letter to the pharmaceutical company to conduct clinical trials of this drug in the United States.

At the invitation of the Chinese government, Xinde Pharmaceuticals shipped a batch of Aparanil to the United States for clinical trials.

The trial results surprised the FDA.

Ibrutinib produced by Xinde Pharmaceutical Affiliated Hospital is much more effective and cheaper than cobitinib produced by Pfizer, Johnson & Johnson and other companies.

Immediately after the FDA announced the clinical results, there was a strong response. Many cancer patients and their families requested that the drug be imported from China immediately.

Simultaneously.

The two pharmaceutical giants, Pfizer Group and Johnson & Johnson, which are the original drug manufacturers of Cobitinib, shifted their attention to Ibrutinib very early!
"What to do, what do you say?"

"Cobitinib is a patent purchased by our group and Johnson & Johnson, and there is still a long time before the patent is valid!"

"Everyone think carefully about whether there is any way to prevent Xinde Pharmaceutical's ibrutinib from entering the US market!"

"We can't just watch huge profits and wealth go to waste!"

At a group high-level meeting, the president of Pfizer roared.

Ibrutinib has been approved by the FDA, and it will be a matter of time before it enters the US market.

The heads of various departments remained silent as they did not want to offend the president.

"Pfizer has been established for nearly 200 years. It has gone through countless ups and downs before and has not collapsed. It will not fail this time!"

"We must not let the foundation created by our ancestors be destroyed in our hands!"

"Leader of the legal department, can you tell me if we can find someone to prevent ibrutinib from entering the market, for example, how about their drug conflicting with ours?"

Seeing that everyone was silent, the president asked by name.

"This one……"

"I'm afraid it won't work. Now the medical community has a high evaluation of this drug, and the majority of patients are also very vocal about it. It may be difficult to prevent ibrutinib from coming in!"

The person in charge of the legal department stood up and said.

But in my heart I feel a little disapproving.

The group has always been engaged in monopoly operation. When did the group start to use such naive reasons to prevent drugs from other countries from entering the domestic market.

It seems that the era of Pfizer dominating the pharmaceutical industry is over.

Gone are the good old days.

"What about the laboratory?"

"Can you prove that ibrutinib and our cobitinib are the same drug or a similar drug?"

The president's gaze focused on the laboratory supervisor again.

"Sorry, we can't prove any connection between the two drugs, nor can we clarify which substance the so-called ibrutinib is!"

The director of the laboratory said ashamedly.

Of course he knew what the president meant.

If it can be proved that ibrutinib and cobitinib are similar substances, the pharmaceutical factory affiliated to Medical University has violated their patent rights.

Foreign sales will also be investigated for legal responsibility.

If Pfizer can easily manufacture similar drugs if it knows the chemical composition of ibrutinib, it might be able to compete with Xinde Pharmaceutical and even make a fortune.

just.

The laboratory supervisor shook his head vigorously.

He let the president down.

"Could it be that we really have nothing to do?" The president said in a sad tone for the first time in his life in front of everyone: "Can we just let others slaughter us?"

"It's not that we have no way!"

"I have an idea!"

"Didn't the big pharmaceutical companies in Asan always want to buy our patents? Before ibrutinib became bigger and those companies in Asan hadn't realized its power, we could sell the patent rights to them. Pass on the risk!"

"Although this is not authentic, it is the only way I can think of to save us!"

The person in charge of the sales department stood up and said.

The people under him who work in Ah Sanguo have the worst performance, because there are pirated drugs everywhere, and no one buys the original products.

Now the head of sales is thankful that he didn't lay off those employees.

If it weren't for this, he wouldn't be able to understand that Ah San's company is so enthusiastic about the original production process.

"Okay, let's do it!"

"Ah San and those guys have been infringing on our patent rights for a long time, it's time for them to suffer!"

(End of this chapter)